Science Examines Use Of Experimental Ebola Vaccine In DRC Outbreak

Science: Congo’s Ebola outbreak is all but over. Did an experimental vaccine help?
“…The quick end to this outbreak — after 53 cases in Équateur province, 29 of which were fatal — is a striking contrast to the Ebola epidemic that devastated West Africa from 2014 to 2016 … [A] new factor played an unknown, and perhaps important, role: an experimental vaccine, used for the first time early in an outbreak. No one can say for sure that the vaccine … actually protected against infection. But DRC Minister of Health Oly Ilunga Kalenga calls the vaccination program a ‘game changer,’ as it clearly boosted morale and encouraged other public health efforts…” (Cohen, 7/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.